| NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
| 501 Sahlgrenska |
| Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
| Benign sample | 310 | 1.3% | 113 | 0.5% | 48 | 0.2% | 4 | 0.0% | 1 | 0.0% | 4 | 0.0% | 22835 | 97.9% | 23315 | 100.0% |
| ASCUS | 761 | 27.3% | 657 | 23.6% | 260 | 9.3% | 8 | 0.3% | 4 | 0.1% | 17 | 0.6% | 1078 | 38.7% | 2785 | 100.0% |
| LSIL | 128 | 25.0% | 176 | 34.4% | 85 | 16.6% | 1 | 0.2% | 2 | 0.4% | 4 | 0.8% | 115 | 22.5% | 511 | 100.0% |
| Atypical glandular cells/AGC | 1 | 10.0% | 3 | 30.0% | 2 | 20.0% | 1 | 10.0% | 3 | 30.0% | . | . | . | . | 10 | 100.0% |
| Unclear atypia | 2 | 66.7% | 1 | 33.3% | . | . | . | . | . | . | . | . | . | . | 3 | 100.0% |
| ASC-H | 9 | 8.3% | 26 | 23.9% | 65 | 59.6% | 1 | 0.9% | 5 | 4.6% | 1 | 0.9% | 2 | 1.8% | 109 | 100.0% |
| HSIL | 6 | 4.0% | 15 | 10.0% | 116 | 77.3% | 2 | 1.3% | 8 | 5.3% | . | . | 3 | 2.0% | 150 | 100.0% |
| Suspected Adenocarcinom | . | . | 1 | 25.0% | . | . | 1 | 25.0% | 2 | 50.0% | . | . | . | . | 4 | 100.0% |
| Totalt | 1217 | 4.5% | 992 | 3.7% | 576 | 2.1% | 18 | 0.1% | 25 | 0.1% | 26 | 0.1% | 24033 | 89.4% | 26887 | 100.0% |
| NOTE: Histopathological outcome from T83x taken into account. |
| This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
| * Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
| The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
| Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
| Snomed codes in the category Cancer: |
|---|
| M80413, M80703, M81403 |